- Report
- September 2022
- 181 Pages
Europe
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- August 2023
- 131 Pages
Middle East, Africa
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- August 2023
- 158 Pages
Europe
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- August 2023
- 151 Pages
Asia Pacific
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- August 2023
- 131 Pages
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- August 2023
- 148 Pages
North America
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- September 2022
- 185 Pages
Asia Pacific
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- September 2022
- 162 Pages
Middle East, Africa
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- September 2022
- 152 Pages
From €2052EUR$2,100USD£1,713GBP
€2931EUR$3,000USD£2,447GBP
- Report
- June 2022
- 259 Pages
Global
From €3112EUR$3,185USD£2,598GBP
€4446EUR$4,550USD£3,711GBP
- Report
- October 2023
- 182 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- March 2023
- 115 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- June 2022
- 117 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- January 2022
- 121 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- November 2023
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Report
- November 2023
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2223EUR$2,275USD£1,856GBP
€3175EUR$3,250USD£2,651GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2223EUR$2,275USD£1,856GBP
€3175EUR$3,250USD£2,651GBP
- Drug Pipelines
- February 2022
- 154 Pages
Global
From €3898EUR$3,990USD£3,255GBP
€5569EUR$5,700USD£4,649GBP
- Report
- February 2022
- 308 Pages
Global
From €6497EUR$6,650USD£5,424GBP
€9282EUR$9,500USD£7,749GBP
The Colon Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy.
Chemotherapy drugs are used to kill cancer cells and stop them from growing. Targeted therapy drugs are designed to target specific cancer cells and block their growth. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer cells.
Some of the major companies in the Colon Cancer Drugs market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and marketing of drugs used to treat colon cancer. Show Less Read more